BBS Pharmaceuticals is a South Australian cannabis company based out of Adelaide. They focus on the cultivation, production and manufacturing of medicinal cannabis products for Australia and internationally.
Their focus is to be the leader in Australia’s manufacturing of medical-grade cannabis and to obtain strong relationships with South East Asian countries importing medical cannabis products. Australia’s potential influence on the South East Asian market is overwhelming. A market exponentially larger than our own is looking for international partners to import medical cannabis products.
John Dagas, CEO, is experienced in business, strategy, civil engineering and has played various senior executive roles in South Australian companies. BBS Pharmaceuticals is looking to John for leadership and focus that will secure a spot in Australia and Asia’s cannabis industry.
What’s new with BBS Pharmaceuticals?
February 21, 2020: BBS Pharmaceuticals starts pushing for a stronger social media presence on the Twitter Platform with posts like this.
True success is when you help others be happy.
Here at BBS we believe that people with passion, determination, commitment, and bravery can change the world for the better.
Disclaimer: Cannabis Place may contain information regarding cannabis & other drugs; it is designed for 18+ audiences in regions where cannabis has been decriminalised. This topic may represent illegal activity in certain regions. We do not encourage illegal activity. We understand that readers in locations where cannabis has been legalised may read these articles. Medical Cannabis in Australia is regulated by the Therapeutic Goods Administration and details about Cannabis as a scheduled drug can be found on their website. Please consult with your doctor to find out if Cannabis is right for you. Click here for our full disclaimer
Tasmanian Botanics is a family-owned and runs cannabis cultivation, production and research company. Their focus is to utilise Tasmania's clean environment and their modern cultivation facility to produce medical-grade cannabis for Australian and international distribution.